Sponsor Pipeline

John Kirkwood Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07631325 Axelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma Unresectable Cutaneous Melanoma Not Yet Recruiting
Not specified
NCT07223411 Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and… Locally Advanced Melanoma Recruiting
NCT06599619 Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi Melanoma Recruiting
Disease Areas
Melanoma (3)
Get alerts when John Kirkwood's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free